The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,810.00
Bid: 1,811.00
Ask: 1,811.50
Change: 0.00 (0.00%)
Spread: 0.50 (0.028%)
Open: 1,805.00
High: 1,812.50
Low: 1,797.00
Prev. Close: 1,810.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

MARKET PULSE-Gigatronics, Everyware, Clovis Oncology, Arctic Cat

Mon, 02nd Jun 2014 16:43

(For more market insights, including options activity, click on ; for the Day Ahead newsletter http://link.reuters.com/mex49s; for the Morning News Call newsletter, http://link.reuters.com/nex49s)U.S. stocks edged lower on Monday, falling from record levels asa weaker-than-expected read on manufacturing gave traders anexcuse to sell. The Dow Jones industrial average was up0.11 percent at 16,735.12 and the S&P 500 was up 0.03percent at 1,924.08.

** GOOGLE INC, $561.33, -1.81 pct

Google services are being disrupted in China ahead of thisweek's 25th anniversary of the 1989 crackdown on pro-democracydemonstrators around Beijing's Tiananmen Square, a censorshipwatchdog said on Monday.

** GIGATRONICS INC, $2.65, +119.01 pct

The company said it had received orders valued at about $6.9million from a major aerospace company for the delivery of YIG(Yttrium Iron Garnet) filters used in wireless communication.Gigatronics did not name the customer but said it "will be asupplier of filter systems for all three of the US designed 4thgeneration fighters." Gigatronics also said it was expecting anorder later this year for about $10 million associated with theproduction units.

** EVERYWARE GLOBAL INC, $1.78, +61.82 pct

The company, which sells dinnerware and kitchen gadgets,said on Saturday that its asset-backed loan lenders agreed notto exercise their rights and remedies till June 30 following adefault on certain covenants.

Everyware said it also intends to partially reopen itsMonaca, Pennsylvania facility.

** BEBE STORES INC, $3.36, -17.55 pct

The women's apparel retailer's Chief Executive SteveBirkhold has sold 140,980 shares of the company at an averageprice of $4.07, a regulatory filing late on Friday revealed. (http://link.reuters.com/beq79v)

** NPS PHARMACEUTICALS INC, $33.92, +8.96 pct

London-listed drugmaker Shire Plc has secured a $5billion credit facility for a takeover offer forNew-Jersey-based NPS Pharmaceuticals, The Times of Londonreported on Sunday. Insiders told The Times that an initialapproach to NPS by Shire has been rebuffed.

** MASTEC INC, $32.18, -10.61 pct

The infrastructure construction company said on Sunday thatit now estimates second-quarter revenue of about $1.1 billion,below its previous forecast of $1.15 billion to $1.2 billion.The company cited lower than previously expected revenue fromwireless projects and the oil and gas segment for the revision.

Stifel Nicolaus cut its price target on the stock to $45from $49 on Monday.

** PROTECTIVE LIFE CORP, $58.5, +11.85 pct

Japanese insurer Dai-ichi Life Co is in advancedtalks to buy U.S. peer Protective Life in a deal that could beworth over $5 billion, extending a drive to buy assets abroad asan antidote to a weak domestic outlook.

** CLOVIS ONCOLOGY,

The company reported positive data from an early stage studytesting its experimental lung cancer drug on Friday, but said 22percent of patients experienced high-blood sugar severe enoughto warrant treatment.

The drug - similar to AstraZeneca Plc's AZD9291 - isdesigned to target non-small cell lung cancer containing agenetic mutation.

** BROADCOM CORP, $34.85, +9.35 pct

The chipmaker said it was looking to sell or wind down itscost-intensive cellular baseband business that is hurting itsoperating income due to high research and development costs.

** ARCTIC CAT INC $33.65, -9.79 pct

The maker of all-terrain vehicles and snowmobiles said ChiefExecutive Claude Jordon has stepped down. The company namedChris Twomey as interim CEO.

** NORDION INC $12.86, +7.62 pct

U.S.-based Sterigenics International has sweetened itstakeover offer for Nordion Inc, the Canadian medicalisotope producer, to $805 million after a previous bid failed toattract enough shareholder support, Nordion said on Monday.

** ARIAD PHARMACEUTICALS INC, $6.94, +7.43 pct

The company said longer-term data from two studies of itsleukemia drug, Iclusig, showed that the drug continues to beeffective in patients who have already received treatment.

Iclusig was allowed a restricted return to the U.S. marketin December, after sales were suspended due to safety concerns.

** JUMEI INTERNATIONAL HOLDING LTD, $29.42, +6.98pct

Brokerage JG Capital initiated coverage on the Chineseonline cosmetics retailer's stock with an "overweight" rating,saying it expects Jumei to benefit from the company's strongbrand awareness, large loyal user base and online shopping'sincreasing penetration in China.

** CONN'S INC, $48.345, +3.66 pct

The electronics and home appliance retailer reported abetter-than-expected profit for the first quarter as furnitureand mattress sales jumped about 65 percent.

** AMERICAN REALTY CAPITAL HEALTHCARE TRUST INC,$10.83, +8.84 pct

** VENTAS INC, $64.49, -3.46 pct

Ventas, one of the largest U.S. healthcare real estateinvestment trusts, said it would buy American Realty CapitalHealthcare Trust in a cash-and-stock deal valued at about $2.6billion.

** PENN VIRGINIA CORP, $14.321, -5.66 pct

The oil and gas producer said it would sell its Mississippiassets to an undisclosed buyer for about $72.7 million. Theassets had net production of about 11.9 million cubic feet ofnatural gas equivalent per day during the first quarter.

** MEADWESTVACO CORP, $42.45, +4.61 pct

Activist investor Starboard Value LP reported a 5.6 percentstake in MeadWestvaco and said the packaging materials maker'sstock was "deeply undervalued".

** CENTURY ALUMINUM CO, $14.095, +3.26 pct

Analysts at BofA Merrill Lynch upgraded the company's stockto "neutral", according to StreetInsider.com.

** EXPRESS INC, $12.52, -0.71 pct

** AEROPOSTALE INC, $3.72, -4.86 pct

Nomura Equity Research cut its price targets on the apparelretailers' stocks. The brokerage cut its price target onExpress's shares to $16 from $20, and on Aeropostale's stock to$5 from $6.

** WALTER ENERGY INC, $4.62, -5.33 pct

** ARCH COAL INC, $3.5, -1.69 pct

** ALPHA NATURAL RESOURCES INC, $3.38, +0.00 pct

** PEABODY ENERGY CORP, $16.2, +0.25 pct

The United States on Monday formally announced a plan toslash carbon emissions from the power sector by 30 percentnationwide below 2005 levels by 2030, a key element of PresidentBarack Obama's plan to tackle global warming.

For a factbox, click

** THERAVANCE BIOPHARMA, $27.94, -2.48 pct

Robert W. Baird & Co analyst Brian Skorney downgraded thebiotechnology company's stock to "neutral" from "outperform",saying, "We think the stock may be particularly volatile in thenear term and see little fundamental upside without betterclarity into acceleration of Breo and Anoro sales."

Breo and Anoro are two FDA-approved treatments developed bythe company in collaboration with GlaxoSmithKline Plc for chronic obstructive pulmonary disease, a serious lungcondition.

Theravance said it would split into two publicly traded U.S.companies in April last year, separating some of its mostadvanced respiratory drugs from its other biopharmaceuticaloperations.

** ALLERGAN INC, $170.25, +1.67 pct

** VALEANT PHARMACEUTICALS INC , $131.39, +0.14 pct

Valeant Pharmaceuticals Inc on Monday prepared totake its $53.8 billion takeover bid for Allergan directly to theBotox maker's shareholders, and ally Pershing Square called fora meeting to turn over the target company's board.

For a BREAKINGVIEWS column,

** RICE ENERGY INC, $31.32, -1.29 pct

** ANTERO RESOURCES CORP, $61.98, +0.78 pct

** CHESAPEAKE ENERGY CORP, $29.21, +1.71 pct

** GULFPORT ENERGY CORP, $61.84, +0.50 pct

** RANGE RESOURCES CORP, $92.54, -0.44 pct

** STONE ENERGY CORP, $43.71, -1.53 pct

Natural gas producer Rice Energy, which went public earlierthis year, said it had successfully tested its first Utica Shalewell in Ohio.

The well, the Bigfoot 9H, had a stabilized production rateof 41.69 million cubic feet per day (mmcf/d) of gas, the companysaid. The market estimate was at about 30 mmcf/d, analysts atTudor, Pickering, Holt & Co said in a note.

The high production rate was a positive for otherexploration and production companies with exposure to the drygas window of the Utica, analysts said.

** AMTRUST FINANCIAL SERVICES INC, $41.43, -2.97pct

An article on Barron's weekly said the property and casualtyinsurer could be under-reserved due to certain accountingdisparities. (http://r.reuters.com/kaq79v)

(Compiled by Shubhankar Chakravorty in Bangalore; Editing bySriraj Kalluvila)

More News
1 Feb 2024 09:03

LONDON BROKER RATINGS: Barclays cuts Next; JPMorgan raises easyJet

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning:

Read more
1 Feb 2024 07:42

LONDON BRIEFING: Shell profit falls; announces USD3.5 billion buyback

(Alliance News) - Stocks in London are set to follow New York into the red, after the US Federal Reserve quashed hopes of a March cut to interest rates and ahead of the Bank of England interest rate decision.

Read more
31 Jan 2024 17:05

LONDON MARKET CLOSE: Stocks mixed hours before expected US Fed hold

(Alliance News) - Stock prices in London closed mixed on Wednesday in a trade-thinned day ahead of the US Federal Reserve interest rate decision this evening.

Read more
31 Jan 2024 15:49

London close: Stocks mixed ahead of US Fed, BoE decisions

(Sharecast News) - London's financial markets finished with mixed performance on Wednesday, with investors closing their wallets ahead of rate announcements from both the US Federal Reserve and the Bank of England.

Read more
31 Jan 2024 12:05

LONDON MARKET MIDDAY: FTSE 100 flat ahead of Federal Reserve decision

(Alliance News) - The FTSE 100 in London was flat heading into Wednesday afternoon, as the US Federal Reserve's latest interest rate decision edges closer, keeping equity market enthusiasm to a minimum.

Read more
31 Jan 2024 09:13

TOP NEWS: GSK profit up on Arexvy boost in 2023 but total payout down

(Alliance News) - GSK PLC reported an increase in profit and revenue for 2023 as revenue for HIV medicine had stable growth, amid optimism in the company's outlook.

Read more
31 Jan 2024 08:55

LONDON MARKET OPEN: Stocks lack direction ahead of Fed, BoE

(Alliance News) - Stock prices in London lacked direction at the open on Wednesday, as investors nervously look ahead to interest rate decisions from the US Federal Reserve and Bank of England.

Read more
31 Jan 2024 07:46

LONDON BRIEFING: Stocks called up; GSK revenue and profit up

(Alliance News) - Stocks in London are called to open higher, as markets share of nerves around the next set of interest rate decisions.

Read more
29 Jan 2024 08:51

GSK seeks expanded use of RSV vaccine in EU, wins approval for Omjjara

(Alliance News) - GSK PLC on Monday celebrated regulatory progress for two of its products in the EU.

Read more
29 Jan 2024 07:43

LONDON BRIEFING: Superdry looks at saving costs; Ferrexpo loses case

(Alliance News) - Stocks in London are expected to start the week on a cautious note, as investors nervously look ahead to two key interest rate decisions.

Read more
29 Jan 2024 07:07

GSK gets EU approval to sell blood cancer treatment Omijara

(Sharecast News) - Biopharma giant GSK has been given the green light by European regulators to sell Omjjara, its treatment for patients with a rare type of blood cancer.

Read more
26 Jan 2024 10:47

Citi hikes target price for GSK but stays 'neutral'

(Sharecast News) - Shares in biopharma giant GSK were rising on Friday, helped by forecast upgrades from Citi, which raised its target price on the stock from 1,535p to 1,700p.

Read more
24 Jan 2024 15:08

Private equity firm Yellow Wood close to deal to acquire ChapStick-sources

Jan 24 (Reuters) - Private equity firm Yellow Wood Partners is in advanced talks to acquire ChapStick, a lip balm brand, from Haleon Plc, the former consumer health division of drug developer GSK Plc, four people familiar with the matter said.

Read more
24 Jan 2024 14:34

UK earnings, trading statements calendar - next 7 days

Thursday 25 January 
Britvic PLCTrading Statement
Conduit Holdings LtdTrading Statement
CVS Group PLCTrading Statement
Dr Martens PLCTrading Statement
Fevertree Drinks PLCTrading Statement
Foxtons Group PLCFull Year Results
Fuller, Smith & Turner PLCTrading Statement
Halfords Group PLCTrading Statement
Idox PLCFull Year Results
IG Group Holdings PLCHalf Year Results
Intermediate Capital Group PLCTrading Statement
Mitie Group PLCTrading Statement
NCC Group PLCHalf Year Results
Newmark Security PLCHalf Year Results
Next 15 Group PLCTrading Statement
PPHE Hotel Group LtdTrading Statement
Secure Trust Bank PLCTrading Statement
St James's Place PLCTrading Statement
Time Finance PLCHalf Year Results
Titon Holdings PLCFull Year Results
Wizz Air Holdings PLCQ3 Results
Workspace Group PLCTrading Statement
Friday 26 January 
Paragon Banking Group PLCTrading Statement
Record PLCTrading Statement
Superdry PLCHalf Year Results
Taylor Maritime Investments LtdTrading Statement
WH Smith PLCTrading Statement
YouGov PLCTrading Statement
Monday 29 January 
Team Internet Group PLCTrading Statement
Tuesday 30 January 
Diaceutics PLCTrading Statement
Diageo PLCHalf Year Results
Kromek Group PLCHalf Year Results
Luceco PLCTrading Statement
Oxford Cannabinoid Technologies Holdings PLCHalf Year Results
Pets at Home Group PLCTrading Statement
Renewi PLCTrading Statement
Saga PLCTrading Statement
SSP Group PLCTrading Statement
SThree PLCFull Year Results
Synthomer PLCTrading Statement
Wednesday 31 January 
Aberforth Smaller Companies Trust PLCFull Year Results
abrdn Private Equity Opportunities Trust PLCFull Year Results
Ecora Resources PLCTrading Statement
GSK PLCFull Year Results
ITM Power PLCHalf Year Results
NWF Group PLCHalf Year Results
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
22 Jan 2024 21:22

Fate of most remaining Zantac lawsuits weighed by Delaware judge

Jan 22 (Reuters) - GSK, Pfizer and other pharmaceutical companies are urging a judge in Delaware this week to find that evidence plaintiffs' lawyers want to use in about 72,000 lawsuits claiming that the discontinued heartburn drug Zantac caused cancer is not supported by science.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.